IPOs, NIH Rift, Biotech Slowdown, Riyadh Deals
Kilder
- Endpoints: Parkinson's cell therapy biotech Aspen and I&I startup Bambusa file for IPOs
- STAT: STAT+: Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role
- BioPharma Dive: This week in charts: What’s driving biotech’s recent pullback?
- Finance: This week in charts: What’s driving biotech’s recent pullback? - Yahoo Finance
- Labiotech: Saudi Arabia’s biotech momentum: inside RGMBS 2026
- Finance: Saudi Arabia's biotech momentum: inside RGMBS 2026｜Beyond Biotech - finance.biggo.com
- Finance: Aldayel: Riyadh Biotech Summit Deals Jumped 13-Fold to $1.3 Billion, With a 2027 Vaccine Plant Next - BigGo Finance
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.